Cluster	Data Abbreviation	Data Description
Study reference	Author	Primary author of reference
	Full title	Full title
	YoP	Year of publication
	YoE	Year of execution
Study design	Design	Design of study
	Specific setting of study	Multi/single center
		Type of hospital
		Number of beds
		Specific wards?
	Country	Country where study was performed
	Funding	Was the study funded?
	C.o.I.	Have the authors reported a conflict of interest?
	Objective	Description of the main objective of the conducted study
Method	Inclusion criteria	All inclusion criteria as reported in original study
	Exclusion criteria	All exclusion criteria as reported in original study
	Usual care	Description of usual care
	Years of experience	Years of experience from the performer
	Protocol training	What kind of training was received by personnel performing the intervention?
	According to protocol	Did the personnel have protocols to perform the intervention?
	Who is collaborating with the pharmacist?	Who: Which other health care providers performed an intervention?
		What: Describe the intervention of the OTHER health care provider
		Communication: How did they communicate?
	Access to medical information	Does the performing pharmacist have access to medical information and in what way?
	Pharmacy intervention	When: At what time during hospitalization is the pharmacy intervention performed?
		What: Description of intervention performed
		Who: Which member of the pharmacy staff is performing the intervention?
		Time spent: Total time spent of intervention
Patient characteristics	Total Nr. assessed	Number of patients that are assessed for eligibility in the study
	Total Nr. randomized	Number of patients that are randomized in the study
	Significant differences at baseline	Are there significant differences at baseline?
		Describe the differences
	Nr. randomized patients: I and C	Number of patients in intervention group and control group after randomization
	Male %	Percentage of men in study
	Age: I and C	Mean age, range and standard deviation of intervention and control groups
	Health state	Main: Primary diagnosis of population group (e.g., heart failure)
		Total number of comorbidities
		How are the total number of comorbidities measured?
	Nr. medication	When: At what time during hospitalization?
		Mean number, range, and standard deviation of medication in intervention and control groups
	% living alone: I and C	Percentage living alone in intervention and control groups
	Nr of hospitalizations	Mean number of previous hospitalizations in intervention and control groups
		Time: during which time frame?
	Other demographic information	If mentioned in study, for example, education, ethnicity, social class
Outcomes	Outcomes	Outcome in short
		Primary outcome
		Definition: report the outcome as described by authors
		Method: how is the outcome measured?
		When: when is the outcome measured (=endpoint)?
		What: what is exactly measured?
	Nr. of patients analyzed	Number of patients in intervention group and control group for analysis
		Characteristics of the (different) outcomes
		Statistics of the outcomes
	Other outcomes	Definition, method, endpoint of measurement, percentages, significance
Other	Limitations	Limitations as mentioned by the authors
	Conclusion	Conclusion as mentioned by the authors
	Comments	Relevant/notable comments
Reviewer	Name	Clementine Stuijt or Rik Ensing
	Date	Date of data extraction
	Check	Checked by second reviewer: type name